Bandingkan Harga & Kinerja NFC Indonesia Tbk. (NFCX) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan NFC Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: NFC Indonesia Tbk. diperdagangkan di Rp1.740 (kapitalisasi pasar 1,13 T, volume 24 jam 3,2 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: NFC Indonesia Tbk. jauh lebih besar — sekitar 10,8× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| NFCX | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,13 T | 104,4 M |
Volume | 3,2 rb | — |
Lot | 32 | — |
Perputaran | 5,51 jt | — |
Harga Rata-rata | 1.722,34 | — |
Nilai Transaksi | 5,51 jt | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang NFC Indonesia Tbk.
PT NFC Indonesia Tbk (the Company) was established based on Notarial Deed No. 14 of Rose Takarina, S.H. dated August 26, 2013.
Selengkapnya di halaman NFCX →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
